Macrobrachium rosenbergii nodavirus (MrNV)-CP-RNA-2 DNA vaccine confers protective immunity in giant freshwater prawn Macrobrachium rosenbergii against MrNV infection
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Fish & Shellfish Immunology
- Vol. 86, 319-326
Abstract
No abstract availableKeywords
Funding Information
- University Grants CommissionUniversity Grants Commission (UGC)
- Government of India, New Delhi (F. 5-37/2014)
This publication has 37 references indexed in Scilit:
- Viral diseases of the giant fresh water prawn Macrobrachium rosenbergii: A reviewJournal of Invertebrate Pathology, 2011
- Herbal biomedicines: a new opportunity for aquaculture industryAquaculture International, 2009
- Optimization and delivery of plasmid DNA for vaccinationExpert Review of Vaccines, 2006
- DNA Vaccines: Recent Developments and Future PossibilitiesHuman Gene Therapy, 2006
- Experimental transmission and tissue tropism of Macrobrachium rosenbergii nodavirus (MrNV) and its associated extra small virus (XSV)Diseases of Aquatic Organisms, 2004
- Extra small virus‐like particles (XSV) and nodavirus associated with whitish muscle disease in the giant freshwater prawn,Macrobrachium rosenbergiiJournal of Fish Diseases, 2003
- A sandwich enzyme linked immunosorbent assay (S‐ELISA) for detection of MrNV in the giant freshwater prawn, Macrobrachium rosenbergii (de Man)Journal of Fish Diseases, 2003
- A viral disease associated with mortalities in hatchery-reared postlarvae of the giant freshwater prawn Macrobrachium rosenbergiiDiseases of Aquatic Organisms, 1999
- Haematological and phenoloxidase activity changes in the shrimpPenaeus stylirostrisin relation with the moult cycle: protection against vibriosisFish & Shellfish Immunology, 1997
- Freshwater prawn culture: a reviewAquaculture, 1990